N6-methyladenosine-modified circ_104797 sustains cisplatin resistance in bladder cancer through acting as RNA sponges

N6-methyladenosine-modified circ_104797 sustains cisplatin resistance in bladder cancer through acting as RNA sponges

Abstract Background Bladder cancer (BCa) ranks among the predominant malignancies affecting the urinary system. Cisplatin (CDDP) remains a cornerstone therapeutic agent for BCa management. Recent insights suggest pivotal roles of circular RNA (circRNA) and N6-methyladenosine (m6A) in modulating CDDP...

Full description

Bibliographic Details
Main Authors: Congjie Xu, Jiaquan Zhou, Xiaoting Zhang, Xinli Kang, Shuan Liu, Mi Song, Cheng Chang, Youtu Lin, Yang Wang
Format: Article
Language:English
Published: BMC 2024-02-01
Series:Cellular & Molecular Biology Letters
Subjects:
Bladder cancer
Cisplatin resistance
circ_104797
miR-103a
N6-methyladenosine
Online Access:https://doi.org/10.1186/s11658-024-00543-3

Internet

https://doi.org/10.1186/s11658-024-00543-3

Similar Items